AzTrials
AzTrials

Shoulder InstabilityFOLAINCT04972331

Automated AI Voice Calls for Postoperative Follow-up After Arthroscopic Shoulder Instability Surgery

A study testing SMS Pre-notification and No Pre-notification in people with Shoulder Instability, run by Institut de Chirurgie Reparatrice Locomoteur et Sports at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective, single-center randomized clinical trial evaluates the technical efficacy, accuracy, and operational performance of an automated conversational artificial intelligence (AI) voice agent for postoperative follow-up after arthroscopic shoulder instability surgery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Shoulder Instability
What is being tested?
SMS Pre-notification and No Pre-notification
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
310 participants
Where
1 siteFrance
Study dates
27 Jan 2026to 13 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥18 years
  • History of arthroscopic shoulder instability surgery
  • Minimum postoperative follow-up of 12 months
  • Valid telephone contact information

Who cannot join

  • Previous ipsilateral surgery
  • Non-consent

Trial locations and contacts

1 site in 1 country.

France1 site
  • ICR Clinique Kantys Centre

    Nice, 06000

Other trials in France

About this study

Official title: Automated AI Voice Calls for Postoperative Orthopedic Follow-up: A Randomized Trial of SMS Pre-notification and Blinded Validation of PROM Capture.

This prospective, single-center randomized clinical trial evaluates the technical efficacy, accuracy, and operational performance of an automated conversational artificial intelligence (AI) voice agent for postoperative follow-up after arthroscopic shoulder instability surgery. The study examines whether SMS pre-notification improves survey completion during the first automated outbound call and assesses the accuracy of AI-captured patient-reported outcomes compared with blinded human review.

Read the detailed description

Participants who underwent arthroscopic shoulder instability surgery at least one year prior were contacted using an automated AI voice agent to collect standardized postoperative outcomes. Patients were randomized 1:1 to receive an SMS pre-notification prior to the first automated call or no pre-notification. The AI agent conducted structured interviews and classified call outcomes using a prespecified taxonomy. A hybrid protocol combining automated outbound calls, inbound callbacks, and targeted human follow-up was implemented to maximize data capture while minimizing resource use. All completed calls were independently audited by a blinded human reviewer to assess agreement with AI-extracted outcomes.

Being tested
SMS Pre-notification, No Pre-notification

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SMS Pre-notificationOther

    Participants received an SMS text message approximately 2 hours before the first automated outbound call.

  • No Pre-notificationProcedure or surgery

    Participants received no SMS prior to the first automated outbound call.

Study groups in NCT04972331
Study groupRoleWhat they receive
CONTROLActive comparatorNo Pre-notification
Receives: Other: SMS Pre-notification
INTERVENTIONExperimentalSMS Pre-notification
Receives: Procedure: No Pre-notification

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Survey completion during the first automated outbound call

    Proportion of participants who completed the automated survey during the first outbound call attempt.

    Measured: 1 week

Secondary outcomes (2)
  1. Survey completion within the first attempt window (including inbound callbacks)

    Completion during or following the first outbound call, including patient-initiated inbound callbacks.

    Measured: 1 week

  2. Call outcome distribution

    Classification of call outcomes using a prespecified taxonomy

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2021
  2. Study start27 Jan 2026
  3. Primary completion6 Feb 2026
  4. Study completion13 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
310 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04972331
Sponsor's protocol ID
2025-190920-01
Other IDs
2025
Acronym
FOLAI
Status last verified
Feb 2026
First submitted
15 Jul 2021
Last updated
20 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Li J, Zhang Y, Zhang Z, Zhou Y, Gao Y, Li X, Fan S. A randomized controlled trial of a WeChat-based artificial intelligence agent for postoperative care in orthopedic patients. NPJ Digit Med. 2026 Jan 17;9(1):105. doi: 10.1038/s41746-025-02269-8.

    PubMed 41548028
  • Dal Grande E, Chittleborough CR, Campostrini S, Dollard M, Taylor AW. Pre-Survey Text Messages (SMS) Improve Participation Rate in an Australian Mobile Telephone Survey: An Experimental Study. PLoS One. 2016 Feb 26;11(2):e0150231. doi: 10.1371/journal.pone.0150231. eCollection 2016.

    PubMed 26919558
  • Nayak A, Vakili S, Nayak K, Nikolov M, Chiu M, Sosseinheimer P, Talamantes S, Testa S, Palanisamy S, Giri V, Schulman K. Use of Voice-Based Conversational Artificial Intelligence for Basal Insulin Prescription Management Among Patients With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2023 Dec 1;6(12):e2340232. doi: 10.1001/jamanetworkopen.2023.40232.

    PubMed 38039007

Questions about this trial

What is this clinical trial studying?

A study testing SMS Pre-notification and No Pre-notification in people with Shoulder Instability, run by Institut de Chirurgie Reparatrice Locomoteur et Sports at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Survey completion during the first automated outbound call (time frame: 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04972331, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in